Stop Pills That Kill Act
Key claim: The Stop Pills That Kill Act expands criminal penalties for manufacturing fentanyl and counterfeit substances, requires DEA to implement a counterfeit fentanyl/methamphetamine enforcement and education plan, and mandates annual DOJ reporting on related law enforcement activity.
Abstract
(S3087 · 119th Congress) Stop Pills That Kill Act This bill increases criminal penalties for offenses relating to the manufacture of fentanyl or counterfeit substances. It also establishes requirements for federal agencies to address the use of counterfeit substances. Specifically, the bill applies an increased criminal penalty for possessing, manufacturing, or distributing certain equipment or materials that are used to illegally manufacture fentanyl, an analogue of fentanyl, or a counterfeit substance (the increased penalty is currently limited to offenses involving methamphetamine). The Drug Enforcement Administration must establish and implement a plan to address counterfeit fentanyl or methamphetamine substances through law enforcement action and education and prevention efforts. In addition, the Department of Justice must annually report on the collection of counterfeit fentanyl or methamphetamine substances by law enforcement and on related prosecutions. Latest action (2025-10-30): Read twice and referred to the Committee on the Judiciary.
Why this matters
The bill adds another layer of federal criminal exposure and agency reporting obligations targeting counterfeit fentanyl and methamphetamine manufacturing, reflecting continuing congressional emphasis on supply-side interdiction of synthetic opioids. Fiscally, it imposes new planning and annual reporting workloads on DEA and DOJ without establishing dedicated funding, and it expands sentencing exposure for defendants charged with manufacturing counterfeit pills. Status is introductory, so practical impact depends on committee action and integration with broader drug enforcement authorities.